![Citeline Podcasts artwork](https://is1-ssl.mzstatic.com/image/thumb/Podcasts113/v4/0f/4f/ef/0f4fef8f-28fc-8de1-8d89-184cfda23e39/mza_5528053617673757912.jpg/100x100bb.jpg)
Device Week, March 8, 2018 – CMS Reorg, FTC Contact Lenses, Aneurysm Devices And Patents
Citeline Podcasts
English - March 09, 2018 21:12 - 15.2 MB - ★★★★★ - 24 ratingsBusiness News Business News Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
On this week's podcast, we discuss medtech policy developments at several federal agencies, including the US Centers for Medicare and Medicaid Services, the Federal Trade Commission, FDA and the US Patent and Trademark Office. For more information on Medtech Insight and to start a free trial, click here: bit.ly/2w7LnlR
Medtech Insight articles addressing topics discussed in this episode:
US CMS Coverage Office Reorganizes In Effort To Improve Efficiency http://bit.ly/2FvGtAY
Contact Lens Proposals From US Trade Commission To Be Scrutinized This Week http://bit.ly/2oXuIx2
Brain Trust Advises US FDA On Aneurysm Device Trials http://bit.ly/2oJZl9d
Neuro Panel Takeaways: Detailed Responses On Aneurysm Devices From US FDA Advisors http://bit.ly/2DfNJ21
A Post-IPR World Would Hold Patent Risks And Benefits For Medtech Companies http://bit.ly/2FAGGGD